---
figid: PMC7710136__SB-MCPJ200054F009
figtitle: Cross-talk between metabolic, inflammatory and muscle growth pathways in
  dystrophic muscle
organisms:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Sequoia sempervirens
- Theilers encephalomyelitis virus
- Desulfovibrio vulgaris
pmcid: PMC7710136
filename: SB-MCPJ200054F009.jpg
figlink: pmc/articles/PMC7710136/figure/F9/
number: F9
caption: Cross-talk between metabolic, inflammatory and muscle growth pathways in
  dystrophic muscle. Upstream regulator and canonical pathway analyses were integrated
  to generate an explanatory schema of processes occurring in dystrophic muscle. Drugs
  with the potential to treat DMD are shown in purple. Activation of NF-κB was not
  predicted based on our data but has been well-described in dystrophic muscle. ILK
  Signaling was enriched in dystrophic muscle, although the analysis did not determine
  an activation state.
papertitle: Mutation-independent Proteomic Signatures of Pathological Progression
  in Murine Models of Duchenne Muscular Dystrophy.
reftext: Tirsa L. E. van Westering, et al. Mol Cell Proteomics. 2020 Dec;19(12):2047-2067.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8620985
figid_alias: PMC7710136__F9
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
redirect_from: /figures/PMC7710136__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7710136__SB-MCPJ200054F009.html
  '@type': Dataset
  description: Cross-talk between metabolic, inflammatory and muscle growth pathways
    in dystrophic muscle. Upstream regulator and canonical pathway analyses were integrated
    to generate an explanatory schema of processes occurring in dystrophic muscle.
    Drugs with the potential to treat DMD are shown in purple. Activation of NF-κB
    was not predicted based on our data but has been well-described in dystrophic
    muscle. ILK Signaling was enriched in dystrophic muscle, although the analysis
    did not determine an activation state.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNG
  - TNF
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - ATIC
  - HDAC4
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ILK
  - MEF2C
  - SIRT1
  - AKT1
  - AKT2
  - AKT3
  - RICTOR
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - PPARGC1A
  - PPARA
  - NFKB1
  - NFKBIA
  - CDC42
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - TFAM
  - ESRRA
  - CYCS
  - Ifng
  - Tnf
  - Hdac4
  - Hdac5
  - Pik3r1
  - Ilk
  - Mef2c
  - Sirt1
  - Akt1
  - Rictor
  - Ppargc1a
  - Ppara
  - Nfkb1
  - Cdc42
  - Tfam
  - Esrra
  - Cycs
  - Gm10053
  - Resveratrol
  - PDTC
---
